Klotho and lean mass as novel cardiovascular risk factors in hemodialysis patients

Ana Rita Martins1,2, Sofia Azeredo-Lopes3,4, Sofia Azeredo Pereira5,6

  • 1Nephrology Department, Hospital Santa Cruz, Western Lisbon Hospital Centre, Lisbon, Portugal.

Clinical Kidney Journal
|December 4, 2023
PubMed

Insights

Alpha-Klotho and lean mass are novel cardiovascular risk factors in hemodialysis patients. Higher alpha-Klotho and lean mass levels are associated with reduced mortality risk, while ADMA is linked to peripheral vascular disease.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Patients with chronic kidney disease (CKD) face elevated cardiovascular (CV) risks.
  • Traditional CV risk factors are well-established, but novel factors like α-Klotho, ADMA, and lean mass require further investigation.

Purpose of the Study:

  • To evaluate the association between α-Klotho, ADMA, and lean mass with the risk of peripheral vascular disease (PVD), CV events, and all-cause mortality.
  • To identify novel CV risk factors in patients undergoing hemodialysis.

Main Methods:

  • Observational, prospective, single-center cohort study.
  • Included 200 adult patients on hemodialysis (online hemodiafiltration).
  • Utilized logistic regression, Cox proportional hazards models, and Kaplan-Meier analysis.

Main Results:

  • Increased α-Klotho levels correlated with decreased odds of PVD and CV events.
  • Increased ADMA levels were significantly associated with increased odds of PVD.
  • Higher α-Klotho and lean mass levels were associated with reduced risk of all-cause mortality, independent of confounders.

Conclusions:

  • α-Klotho and lean mass emerge as significant novel predictors of reduced all-cause mortality in hemodialysis patients.
  • These findings support α-Klotho and lean mass as important factors in managing cardiovascular risk in CKD patients.
Abstract

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
99
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
396
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
322
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
96